Erythropoiesis-stimulating agent treatment with full anemia correction: a new perspective-Reference-Cited by-同舟云学术

Erythropoiesis-stimulating agent treatment with full anemia correction: a new perspective

Published:2009-02 Issue:4 Volume:75 Page:358-365
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Fishbane Steven

Publisher

Elsevier BV

Subject

Nephrology

Reference64 articles.

1. Perspectives on the improvement of quality of life with epoetin alfa therapy;Lundin;Pharmacotherapy,1990

2. Normalizationof hemoglobin level in patients with chronic kidney disease and anemia;Drueke;N Engl J Med,2006

3. Correction of anemia with epoitin alf in chronic kidney disease;Singh;N Engl J Med,2006

4. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin;Besarab;N Engl J Med,1998

5. NKF-K/DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure;National Kidney Foundation-Dialysis Outcomes Quality Initiative;Am J Kidney Dis,1997

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythrocytes;Encyclopedia of Respiratory Medicine;2022

2. Сardiorenal Syndrome in Patients on Renal Replacement Therapy;Renal Replacement Therapy [Working Title];2021-11-04

3. Treatment of renal anemia: Erythropoiesis stimulating agents and beyond;Kidney Research and Clinical Practice;2017-09-30

4. Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodialysis patients;International Journal of Nephrology and Renovascular Disease;2016-03

5. Trends in haemoglobin, erythropoietin-stimulating agents and iron use in Swedish chronic kidney disease patients between 2008 and 2013;Nephrology Dialysis Transplantation;2015-08-04